Show simple item record

dc.contributor.authorErden, Zeynep
dc.date.accessioned2018-04-12T14:42:13Z
dc.date.available2018-04-12T14:42:13Z
dc.date.issued2017
dc.identifier.issn1359-6446
dc.identifier.doi10.1016/j.drudis.2016.09.002
dc.identifier.urihttp://hdl.handle.net/20.500.12127/5943
dc.description.abstractFirms in the biopharmaceutical industry send signals to investors about the value of their knowledge by disclosing it in the form of patents and publications. In this way, they can gain reputation even before having products on the market. This paper compares the patenting and publishing activities of university spinoffs with other biopharmaceutical firms. The findings suggest that successful university spinoffs and successful other firms (not university spinoffs) tend to follow different knowledge disclosure strategies. Whereas successful university spinoffs tend to emphasize the scientific value of their knowledge and gain reputation through their high-quality publications, other successful firms tend to emphasize the commercial value of their knowledge and gain reputation through high-quality patents.
dc.language.isoen
dc.publisherElsevier
dc.titleThe publishing and patenting strategies of successful university spinoffs in the biopharmaceutical industry
dc.identifier.journalDrug Discovery Today
dc.source.volume22
dc.source.issue1
dc.source.beginpage5
dc.source.endpage9
dc.contributor.departmentETH Zurich
vlerick.knowledgedomainEntrepreneurship
vlerick.knowledgedomainInnovation Management
vlerick.knowledgedomainSpecial Industries : Healthcare Management
vlerick.typearticleJournal article with impact factor
vlerick.vlerickdepartmentEGS
dc.identifier.vperid237517


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record